Skip to content

Experts say surgeon general's report may change perception of addiction

Experts say surgeon general’s report may change perception of addiction

The U.S. Surgeon General Dr. Vivek Murthy released a 400-page study called “Facing Addiction in America,” covering various aspects of abuse, …
See all stories on this topic

The Alcohol Sensitivity Questionnaire: Evidence for Construct Validity

ConclusionsThe ASQ compared favorably with the better‐known SRE in predicting increased stimulation and reduced sedation following an acute alcohol challenge. The ASQ appears to be a valid self‐report measure of alcohol sensitivity and therefore holds promise for identifying individuals at‐risk for AUD and related problems.

The Alcohol Sensitivity Questionnaire (ASQ), a new retrospective, s
See all stories on this topic

Craving Mediates Stress in Predicting Lapse During Alcohol Dependence Treatment

ConclusionsAmong treatment seeking, alcohol‐dependent patients, craving mediated the relationship between stress and lapse. The effect was not moderated by depressed mood or anticraving medication.

Stress, craving and depressed mood are implicated in alcohol‐use treatment lapses. This prospective study examined a stress–treatment response model that incorporated mediation by craving and mod
See all stories on this topic

FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death

March 22, 2016 — In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose a
See all stories on this topic

FDA requires boxed warnings for short-acting opioids

The Food and Drug Administration will require boxed warnings on the risks of abuse, misuse, addiction, overdose, and death for all immediate-release opioids. The decision is part of the latest wave of efforts by federal officials to combat the ballooning opioid epidemic. It comes a week after the Centers for Disease Control and Prevention issued guidelines recommending nonopioid analgesia for non
See all stories on this topic

Published inAddiction

Be First to Comment

Leave a Reply